BFRI vs BHVN

Biofrontera Inc. vs Biohaven Ltd. — Valuation Comparison 2026

BFRI

Pharmaceutical Preparations
Biofrontera Inc.
Quality
5.6
out of 10
Value Trap
30
LOW
Price
$0.89
Last close
Models
7/13
Active
VS

BHVN

Pharmaceutical Preparations
Biohaven Ltd.
Quality
3.8
out of 10
Value Trap
30
LOW
Price
$11.01
Last close
Models
6/13
Active

Model-by-Model Comparison

ModelType BFRI Fair ValueBFRI Upside BHVN Fair ValueBHVN Upside
Bayesian DCF Intrinsic $0.37 -58.0% $2.44 -77.8%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $1.72 +93.9% $2.20 -80.1%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
RCMH-DCF Intrinsic $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for BFRI vs BHVN — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

BFRI vs BHVN — Which Stock Is More Undervalued?

BFRI scores higher with a 5.6/10 quality rating vs BHVN's 3.8/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Biofrontera Inc. (BFRI) and Biohaven Ltd. (BHVN) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

BFRI currently trades at $0.89 with a QOC of 5.6/10, while BHVN trades at $11.01 with a QOC of 3.8/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).